期刊文献+

HIV/AIDS病人血脂及C-反应蛋白的研究 被引量:3

A study on lipids and C-reactive protein in HIV-infected patients
原文传递
导出
摘要 目的研究艾滋病病毒(HIV)感染者/艾滋病(AIDS)病人(简称HIV/AIDS病人)血脂及C-反应蛋白(CRP)的水平,以探讨HIV/AIDS病人体内这些因子是否与CD4+T细胞数及高效抗反转录病毒治疗(HAART)相关。方法选取2005年1月至2009年12月,在上海市公共卫生临床中心就诊的HIV/AIDS病人348例,流式细胞仪检测CD4+T细胞数,采用全自动生化分析仪测定血脂含量,免疫分析仪测定血清CRP含量。统计分析血脂及CRP与CD4+T细胞数及HAART的关系。结果入选的348例HIV/AIDS病人CD4+T细胞数为47(14~165)个/μl,72例(20.7%)已经开始HAART,HAART时间为6(1-15.75)个月。HAART治疗组与未治疗组病人相比具有较高浓度的总胆固醇、高密度脂蛋白(HDL)和载脂蛋白(Apo)A1,P值分别为:0.0288、0.0004、0.0052。272例(78.2%)CD4+T细胞数≤200/μl病人与76例(21.8%)〉200个/μl的病人相比,具有较低浓度的总胆固醇、高密度脂蛋白(HDL)、载脂蛋白(Apo)A1高浓度CRP,P值分别为:0.0015、0.0000、0.0000、0.0156。多重线性回归分析将年龄、性别、吸烟因素调整后,表明HAART治疗同HDL(β=0.1476,P=0.004)、Apo-A1(β=0.1341,P=0.007)具有独立相关关系,CD4+T细胞数的变化同总胆固醇、HDL、LDL、Apo-A1、Apo-B具有独立相关关系。结论 HIV/AIDS病人CD4+T细胞数及开始HAART治疗同血脂及CRP浓度密切相关,HAART治疗有利于提高HDL、Apo-A1的水平。 Objective To investigate serum lipids and C-reactive protein(CRP) and explore whether these factors are related with CD+4T cells and HAART.Methods Venous blood samples were collected from 348 HIV patients from January 2005 to December 2009 in our center.The CD+4T cells were determined by flow cytometry.serum lipids were assayed by automatic biochemistry analyzer and CRP was assayed by immune analyzer.Stata7.0 was used to analyze data obtained.Results The median absolute CD+4T count was 47(14-165)/μl in 348 cases.Seventy two(20.7%) patients were treated with antiretroviral drugs and the median length was 6(1-15.75)months.ARV-treated patients,as compared with ARV-naive patients,had higher total cholesterol(P=0.0288),HDL(P=0.0004),Apo A1(P=0.0052);272(78.2%) patients with CD+4T count ≤200/μl,as compared with 76(21.8%) with CD+4T count 200/μl,had lower total cholesterol(P=0.0018),HDL(P=0.0000),Apo A1(P=0.0000),higher CRP(P=0.0004).Multiple linear regression analysis showed that current antiretroviral therapy was independent factors associated with HDL(β=0.1476,P=0.004) and Apo A1(β=0.1341,P=0.007) levels,CD+4T cells were independent factors associated with total cholesterol,HDL,LDL,Apo A1 and Apo B levels,adjusting for age,sex and cigarette smoking in these patients.Conclusion The CD+4T cells and antiretroviral therapy were closely related with serum lipids and CRP levels.HAART may improve HDL and Apo A1 levels.
出处 《中国艾滋病性病》 CAS 2011年第2期111-114,共4页 Chinese Journal of Aids & STD
基金 国家十一五重大科技攻关项目(2008ZX10001-008) 上海市优秀学科带头人A类项目(08XD14035)~~
关键词 艾滋病病毒 血脂 C-反应蛋白 Human immunodeficiency virus(HIV) Serum lipids C-reactive protein
  • 相关文献

参考文献14

  • 1Calza L, Manfredi R, Verucchi G, Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical managernent [J].AIDS, 2010,24 (6) : 789 - 802.
  • 2Baker JV, Henry WK, Neaton JD. The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms. [J].Curr Opin HIV AIDS,2009,4(3) : 176-182.
  • 3Tebas P, Henry WK, Matining R, et al. Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk [J]. Plos one, 2008,3 (e20214).
  • 4Lau B, Sharrett A R, Kingsley L A, et al. C-reactive protein is a marker for human immunodeficieney virus disease progression[J]. Archives of Internal Medicine, 2006,166 (1) .64- 70.
  • 5Sanchez F M, Castano M, Linde F A, et al. Value of C-reactive protein is a marker for human immunodeficiency virus disease pro gression[J]. Anales de Medieina Interna, 2007,24 (4)204.
  • 6Boekholdt SM, Kastelein J. C-reactive protein and cardiovascular risk: more fuel to the fire[J]. Lancet,2010,375(9709):95-96.
  • 7Baum MK, Rafie C, Sales S, et al. C-reactive protein: a poor marker of cardiovascular disease risk in HIV plus populations with a high prevalence of elevated serum transarninases[J]. International Journal of STD & AIDS,2008,19(6) :410-413.
  • 8Mujawar Z, Rose H, Morrow MP, et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages[J]. Plos Biology,2006,4(e36511) : 1970-1983.
  • 9Rose H, Hoy J, Woolley I, et al. HIV infection and high density lipoprotein metabolism[J].Atherosclerosis, 2008, 199 (1) 79 - 86.
  • 10Martinez E, Larrousse M, Gatell J M. Cardiovascular disease and HIV infection: host, virus, or drugs? [J]. Current Opinion in Infectious Diseases, 2009,22 (1) 28- 34.

同被引文献26

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部